Shopping Cart
- Remove All
 
Your shopping cart is currently empty
HDAC3 inhibitor is an allosteric inhibitor of histone deacetylase 3 (HDAC3; Ki = 0.16 nM). It is selective for HDAC3 over HDAC1 and HDAC2 (IC50s = 0.95, 11.81, and 95.45 nM, respectively, using recombinant HDACs). In addition, it is selective for acute myeloid, monocytic, and lymphoblastic leukemia cell lines (EC50s = 36.37, 76.64, and 151.7 nM, respectively) over chronic myeloid, acute promyelocytic, and acute lymphoblastic cells (EC50s = 2,160, >10,000, and >10,000 nM, respectively).

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 1 mg | $178 | 35 days | |
| 5 mg | $783 | 35 days | |
| 10 mg | $1,370 | 35 days | 
| Description | HDAC3 inhibitor is an allosteric inhibitor of histone deacetylase 3 (HDAC3; Ki = 0.16 nM). It is selective for HDAC3 over HDAC1 and HDAC2 (IC50s = 0.95, 11.81, and 95.45 nM, respectively, using recombinant HDACs). In addition, it is selective for acute myeloid, monocytic, and lymphoblastic leukemia cell lines (EC50s = 36.37, 76.64, and 151.7 nM, respectively) over chronic myeloid, acute promyelocytic, and acute lymphoblastic cells (EC50s = 2,160, >10,000, and >10,000 nM, respectively).  | 
| Targets&IC50 |  HDAC2:89.9 ± 0.7 nM, HDAC1:36.4 ± 0.2 nM, HDAC3:5.96 ± 0.0 nM  | 
| Molecular Weight | 337.42 | 
| Formula | C20H23N3O2 | 
| Cas No. | 2044701-99-5 | 
| Relative Density. | 1.140 g/cm3 (Predicted) | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 10 mg/mL (29.64 mM), Sonication is recommended.  DMF: 10 mg/mL (29.64 mM), Sonication is recommended.  Ethanol: 30 mg/mL (88.91 mM), Sonication is recommended.   | |||||||||||||||||||||||||
Solution Preparation Table  | ||||||||||||||||||||||||||
DMSO/DMF/Ethanol 
  | ||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.